Industry
Shenzhen Highslab Therapeutics
A Shenzhen biotech applying AI structure prediction and generative sequence design to discover cyclic peptide therapeutics for hard-to-drug targets.
Location: Shenzhen, China
1 model
Models (1)
HighPlay
Macao Polytechnic University / Zhejiang University of Technology / Shenzhen Highslab Therapeutics / Shanghai Jiao Tong University
Released March 17, 2025
10—11
Cyclic peptide binder design by Monte Carlo tree search over sequence space, scored by predicted confidence of the peptide-target complex fold.
Protein